FDA Inspection 1281266 — HAS Healthcare Advanced Synthesis S.A.
The FDA completed an inspection of HAS Healthcare Advanced Synthesis S.A. on Feb 20, 2025 in Biasca. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Feb 20, 2025
- Fiscal Year
- 2025
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Biasca (Switzerland)
Additional Details
Mutual Recognition Agreement (MRA)